ESG Dynamics-SBP GROUP | Sino Biopharmaceutical Limited

Sustainability

Home >Sustainability >ESG Dynamics

Continuous Improvement of Responsible AI Governance Mechanisms

Release Date: 2026-03-12

Previous：Implementation Progress of Phase I Carbon Neutrality Action Plan – Sino Biopharmaceutical Limited
Next：A member subsidiary of SBP GROUP has been awarded the title of Nanjing "Waste-Free Factory"